Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy.
Newcott EK, Ellabban AA, Tavassoli S, Sallam A. Intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy. Case Rep Ophthalmol Med. 2015; 2015:713868.